Biopharma Company Rakes In $145M In Fundraising Effort
Rallybio, a biopharmaceutical company that creates treatments for severe and rare disorders, said Tuesday it raised $145 million in a funding round led by Pivotal bioVenture Partners....To view the full article, register now.
Already a subscriber? Click here to view full article